Latest News about MindMed
Recent news which mentions MindMed
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
From Benzinga
EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences
April 27, 2022
From Benzinga
From Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
From Benzinga
From Benzinga
How This Company Is Using Psychedelic Medicines and Therapies to Treat Addiction and Mental Illness
November 02, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.